Mitochondrial aldehyde dehydrogenase and cardiac diseases
Che-Hong Chen1, Lihan Sun, Daria Mochly-Rosen
1Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA 94305-5174, USA.
Cardiovascular Research
|June 19, 2010
Summary
Aldehyde dehydrogenase 2 (ALDH2) protects the heart by reducing toxic aldehyde buildup caused by oxidative stress. ALDH2 activity is crucial for cardioprotection, offering new therapeutic avenues for cardiovascular diseases.
Area of Science:
- Biochemistry
- Cardiology
- Cell Biology
Background:
- Oxidative stress generates reactive aldehydes, contributing to cellular damage and cardiovascular diseases.
- Aldehyde dehydrogenases (ALDHs) are critical enzymes that detoxify reactive aldehydes.
- Mitochondrial ALDH2 plays a key role in managing cellular aldehyde levels.
Purpose of the Study:
- To review the evidence for mitochondrial ALDH2's role in combating oxidative stress.
- To explore ALDH2's function in reducing the 'aldehydic load' within cells.
- To highlight ALDH2's potential in cardiovascular disease research and treatment.
Main Methods:
- Analysis of epidemiological studies in humans with inactive ALDH2.
- Examination of genetic mouse models with modified ALDH2 expression.
- Review of studies using small molecule ALDH2 activators.
Main Results:
- Evidence consistently links ALDH2 activity to cardioprotection.
- Inactive ALDH2 is associated with increased susceptibility to cardiac damage.
- ALDH2 activation demonstrates therapeutic potential in preclinical models.
Conclusions:
- Mitochondrial ALDH2 is a significant factor in protecting against oxidative stress-induced cardiac damage.
- Targeting ALDH2 offers a promising strategy for developing novel cardiovascular therapies.
- Further research into ALDH2 function is warranted for advancing cardiovascular medicine.
Related Concept Videos
01:46Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
01:48ATP Synthase: Mechanism
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:25Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...